3658 results for «202»

Filter By

3658 results

CAD and TAVI

18 Feb 2024 – From PCR Tokyo Valves 2024

What is the clinical impact of CAD in TAVR recipients and how best to treat it? Through this session, gain insight on how to determine optimal CAD assessment in TAVR recipients, learn the timing of coronary revascularisation pre-TAVR, and understand the exact assessment and treatment of...

CAD and TAVI

TEER for primary mitral regurgitation

18 Feb 2024 – From PCR Tokyo Valves 2024

What are the current indications and future perspectives of using TEER for primary mitral regurgitation? Join this session if you want to gain insight into anatomical evaluation before TEER, learn the procedural strategy for complex primary mitral regurgitation, and explore the specific features of both MitraClip...

TEER for primary mitral regurgitation

TAVI optimisation

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this series of slides to enhance your understanding of TAVI optimisation through selected studies for PCR Tokyo Valves 2024. Learn about the prognostic value of right ventricle dysfunction after TAVR, explore a risk model in dialysis patients following TAVR, and explore the impact of age...

TAVI optimisation

Rapid-fire - Mitral TEER for complex situations

18 Feb 2024 – From PCR Tokyo Valves 2024

This series of rapid-fire submitted cases focuses on mitral TEER for complex situations. Learn about creative solutions to these situations such as clip inversion grasping, independent leaflet grasping with a CGA system, and more!

Managing aortic stenosis in patients with longer life expectancy

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to understand what knowledge is needed for discussions with patients concerning lifetime management of valve disease, gain insight into the importance of predictable and precise commissural and coronary alignment for lifetime management, and learn about the indication of TAV-in-TAV and THV explant.

Tricuspid valve interventions

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session if you want to understand T-TEER/TTVR procedure, learn about clinical indication and appropriate patient selection for TEER/TTVR based on TRILUMINATE trial/TRISCEND study, and update your knowledge of current transcatheter technologies for tricuspid regurgitation.

Tricuspid valve interventions

Challenging situations in mitral valve interventions

18 Feb 2024 – From PCR Tokyo Valves 2024

This selection of cases showcases a number of challenging situations in mitral valve interventions and how best to resolve them. Among such complications are a severe afterload mismatch following M-TEER in functional mitral regurgitation, a detached clip in the left atrium, and more.

Rapid-fire - Outcome studies after valvular intervention

18 Feb 2024 – From PCR Tokyo Valves 2024

This session of rapid-fire submitted cases focuses on outcome studies after valvular intervention. Learn about clinical impacts of cerebral micro-bleeds in patients undergoing TAVI, explore the long-term outcomes of Venus P valve for dysfunctional right ventricular outflow tract, and more!

Useful links in Interventional Cardiology

12 Oct 2016

We would like to share useful information and links to resources with you on Interventional Cardiology, medical professional societies, specialised websites and scoring tools.

PCR Webinars: Bringing the hot topics in interventional cardiology to your home

10 Jun 2024

According to Medical Director of PCR Webinars, Dejan Milasinovic, two novel additions to the platform will increase the interactive experience and take webinar­ based learning to a new level.

PCR Webinars: Bringing the hot topics in interventional cardiology to your home

Transcatheter aortic valve replacement for asymptomatic severe aortic stenosis: Results of the EARLY TAVR trial

29 Oct 2024

Luigi Biasco provides his take on the results of the EARLY TAVR trial, presented by Philippe Genereux at TCT 2024 in Washington.

Luigi Biasco

Author

Luigi Biasco
Transcatheter aortic valve replacement for asymptomatic severe aortic stenosis: Results of the EARLY TAVR trial

EuroPCR 2024: Elixir Medical’s late-breaking 12-month data demonstrate significant improvement in safety and effectiveness of world’s first site-specific antithrombotic therapeutic compared to DES

14 May 2024

The RELIEVE-HF study: is an atrial septal shunt beneficial in HFrEF?

07 Apr 2024

Charles Fauvel provides his take on the RELIEVE-HF study outcomes presented by Gregg W. Stone at ACC.24 in Atlanta.

Charles Fauvel

Author

Charles Fauvel
The RELIEVE-HF study: is an atrial septal shunt beneficial in HFrEF?

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

29 Mar 2025

Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.

Author

Ali Nazmi Calik
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial

29 Mar 2025

Luigi Biasco provides his take on a sub-analysis of the Early TAVR trial about the early and delayed aortic valve replacement implant patients presented by Philippe Genereux at ACC.25 in Chicago.

Luigi Biasco

Author

Luigi Biasco
New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial

Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)

30 Oct 2024

Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.

Author

Ali Nazmi Calik
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)

How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR

09 Mar 2026

Recurrent mitral regurgitation after M-TEER can create a challenging scenario. Discover the ELASTA-Clip technique and its key steps to enable TMVR!

Jonathan Curio

Author

Jonathan Curio

Author

Matti Adam
How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR
Didn’t find what you were looking for?